Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 8, Issue 12 (2019)

Alcoholic liver disease: A review

Author(s):
P Hamsa Rekha, D Sudheer Kumar and P Kishore
Abstract:
Alcoholic Liver Disease (ALD) is the most advanced form of liver disease that’s related to drinking alcohol. The disease is part of a progression. Alcoholic liver disease comprises a clinical-histologic spectrum including fatty liver, alcoholic hepatitis, and cirrhosis with its complications. The diagnosis of ALD can generally be made based on clinical and laboratory features alone in patients with a history of significant alcohol consumption after other etiologies for chronic liver disease have been ruled out. Therapies for treatment of ALD aim at achieving complete alcohol abstinence with use of pharmacological therapy and behavioral therapy with motivational interviewing. Many pharmacological agents have been used for treatment of ALD including disulfiram, acamprosate, gabapentin, naltrexone, topiramate, sertraline, & baclofen. Life style changes help to delay or stop progression of the disease, reduce the severity of symptoms and help to prevent the complications.
Pages: 25-32  |  223 Views  18 Downloads
How to cite this article:
P Hamsa Rekha, D Sudheer Kumar, P Kishore. Alcoholic liver disease: A review. Pharma Innovation 2019;8(12):25-32.
The Pharma Innovation Journal